Evidence map›Paper›PMID 42143625›Full record

ArticleAmerican journal of respiratory cell and molecular biology2026

zDHHC21 loss of function activates lung fibroblasts by regulating PTEN palmitoylation.

Bieerkehazhi Shayahati, Aaron K McDowell-Sanchez, Askar M Akimzhanov, Konstantin Tsoyi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bieerkehazhi ShayahatiDepartment of Biochemistry and Molecular Biology, University of Texas Health Science Center Houston, McGovern Medical School, Houston, TX, United States.
Aaron K McDowell-SanchezSection of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX, United States.
Askar M AkimzhanovDepartment of Biochemistry and Molecular Biology, University of Texas Health Science Center Houston, McGovern Medical School, Houston, TX, United States.
Konstantin TsoyiDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United States.

Funding

Macropinocytosis and Pulmonary FibrosisR01HL176934 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI Konstantin Tsoyi · 2025 to 2026
$1.2M
Antifibrotic effects of Syndecan-2 and CD148 in Rheumatoid Arthritis Interstitial Lung DiseaseK01AR074558 · NIAMS · BAYLOR COLLEGE OF MEDICINE · PI TSOYI, KONSTANTIN · 2020 to 2024
$655k
National Heart, Lung and Blood Institutes HL176934National Institute of Arthritis, Musculoskeletal and Skin Diseases AR074558NHLBI NIH HHS R01 HL176934NIAMS NIH HHS K01 AR074558
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42143625
PMCPMC13424684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.